APOM
Apolipoprotein M
Also known as: Apo-M, APOM_HUMAN, G3a, NG20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O95445
- Gene
- APOM
- Ensembl
- ENSG00000204444
- Chromosome
- 6
- Canonical length
- 188 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is an apolipoprotein and member of the lipocalin protein family. It is found associated with high density lipoproteins and to a lesser extent with low density lipoproteins and triglyceride-rich lipoproteins. The encoded protein is secreted through the plasma membrane but remains membrane-bound, where it is involved in lipid transport. Alternate splicing results in both coding and non-coding variants of this gene. [provided by RefSeq, Jan 2012]
Canonical amino-acid sequenceUniProt
188 residues, UniProt reviewed canonical sequence.
>O95445|APOM
1 MFHQIWAALL YFYGIILNSI YQCPEHSQLT TLGVDGKEFP EVHLGQWYFI AGAAPTKEEL
61 ATFDPVDNIV FNMAAGSAPM QLHLRATIRM KDGLCVPRKW IYHLTEGSTD LRTEGRPDMK
121 TELFSSSCPG GIMLNETGQG YQRFLLYNRS PHPPEKCVEE FKSLTSCLDS KAFLLTPRNQ
181 EACELSNNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against APOM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 449 nTPM
Expression across tissuesHPA
Tissue
- liver: 449 nTPM
- kidney: 111 nTPM
- testis: 15 nTPM
- small intestine: 9.6 nTPM
- skeletal muscle: 7 nTPM
- midbrain: 6.8 nTPM
Single-cell type
- hepatocytes: 694 nCPM
- late primary spermatocytes: 96 nCPM
- enterocytes: 68 nCPM
- early spermatids: 53 nCPM
- late spermatids: 44 nCPM
- epididymal efferent duct absorptive cells: 31 nCPM
Immune cell
- basophil: 3 nTPM
- memory B-cell: 1.1 nTPM
- non-classical monocyte: 0.7 nTPM
- T-reg: 0.7 nTPM
- classical monocyte: 0.6 nTPM
- eosinophil: 0.6 nTPM
Brain region
- cerebellum: 1.4 nTPM
- medulla oblongata: 0.9 nTPM
- white matter: 0.9 nTPM
- cerebral cortex: 0.8 nTPM
- hypothalamus: 0.8 nTPM
- midbrain: 0.8 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.94
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol efflux
- cholesterol homeostasis
- high-density lipoprotein particle assembly
- high-density lipoprotein particle clearance
- high-density lipoprotein particle remodeling
- lipoprotein metabolic process
- negative regulation of plasma lipoprotein oxidation
- reverse cholesterol transport
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Calycin
- Apolipoprotein M
- ApoM domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of APOM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads APOM as an antibody target. Whether an autoantibody or antibody against APOM could matter depends on whether native APOM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
APOM is annotated as secreted, so native APOM circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label APOM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...